- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Warsaw Today
By the People, for the People
OrthoPediatrics Price Target Raised to $20.00
Truist Financial boosts price objective on OrthoPediatrics stock
Published on Mar. 2, 2026
Got story updates? Submit your updates here. ›
Truist Financial has raised its price target on shares of OrthoPediatrics (NASDAQ:KIDS) from $19.00 to $20.00, maintaining a "hold" rating on the stock. The brokerage firm cited the company's recent financial performance and market position in its updated research note.
Why it matters
OrthoPediatrics is a medical device company focused on providing orthopedic solutions for children. The price target increase by Truist Financial suggests cautious optimism about the company's growth prospects, though the "hold" rating indicates analysts see limited upside in the near term.
The details
Truist Financial analysts cited OrthoPediatrics' recent financial results and market positioning in their decision to raise the price target on the stock from $19.00 to $20.00. The brokerage firm maintained its "hold" rating, suggesting they see limited potential for significant share price appreciation in the immediate future.
- The updated price target and rating were issued on Monday, March 2, 2026.
The players
Truist Financial
A major U.S. financial services company that provides banking, insurance, and investment services.
OrthoPediatrics
A medical device company dedicated to providing orthopedic solutions for children, including trauma, deformity correction, spine disorders, and sports injuries.
The takeaway
The price target increase by Truist Financial suggests cautious optimism about OrthoPediatrics' growth prospects, though the "hold" rating indicates analysts see limited upside in the near term. This reflects the company's position as a specialized medical device maker focused on the pediatric orthopedics market.
